Giorgia Riolo, Claudia Dosi, Stefano Parravicini, Riccardo Zanin, Marta Cheli, Eleonora Giacopuzzi Grigoli et al. Myostatin/Smad3 in Spinal Muscular Atrophy: Biomarkers of Disease Severity and Treatment Response. // Annals of Clinical and Translational Neurology. – 2026. – DOI: 10.1002/acn3.70564. – URL: https://onlinelibrary.wiley.com/doi/10.1002/acn3.70564?af=R
Giorgia Riolo, Claudia Dosi, Stefano Parravicini, Riccardo Zanin, Marta Cheli, Eleonora Giacopuzzi Grigoli, Amalia Canciello, Francesca Andreetta, Riccardo Masson, Silvia Bonanno, Stefania Marcuzzo, & Lorenzo Maggi (2026). Myostatin/Smad3 in Spinal Muscular Atrophy: Biomarkers of Disease Severity and Treatment Response. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.70564
Giorgia Riolo, et al. “Myostatin/Smad3 in Spinal Muscular Atrophy: Biomarkers of Disease Severity and Treatment Response.” Annals of Clinical and Translational Neurology, 2026. doi:10.1002/acn3.70564.
@article{Riolo2026,
title = {Myostatin/Smad3 in Spinal Muscular Atrophy: Biomarkers of Disease Severity and Treatment Response},
author = {Riolo, Giorgia and Dosi, Claudia and Parravicini, Stefano and Zanin, Riccardo and Cheli, Marta and Grigoli, Eleonora Giacopuzzi and Canciello, Amalia and Andreetta, Francesca and Masson, Riccardo and Bonanno, Silvia and Marcuzzo, Stefania and Maggi, Lorenzo},
journal = {Annals of Clinical and Translational Neurology},
year = {2026},
doi = {10.1002/acn3.70564},
url = {https://onlinelibrary.wiley.com/doi/10.1002/acn3.70564?af=R}
}